Professor Porrello is the Theme Director of Stem Cell Biology and Head of the Heart Regeneration Group at the Murdoch Children’s Research Institute. He also directs the Melbourne Node of the recently established Novo Nordisk Foundation Centre for Stem Cell Medicine (reNEW) and he is the founding Co-Director of the Melbourne Centre for Cardiovascular Genomics and Regenerative Medicine (CardioRegen). Prof Porrello’s research focuses on the development of regenerative therapies for children and adults with heart failure. Over the course of his career, he has made important contributions to our understanding of mammalian heart regeneration and has pioneered the development of human organoids for drug discovery. Prof Porrello is a co-founder of Dynomics, a biotechnology company focused on the development of new heart failure treatments using organoid technologies.
After completing his PhD in Physiology at The University of Melbourne, Prof Porrello was awarded an NHMRC/NHF C.J. Martin Fellowship to undertake postdoctoral training in Prof Eric Olson's laboratory at UT Southwestern Medical Center in Dallas, USA. Upon returning to Australia in 2012, Prof Porrello established the Cardiac Regeneration Laboratory at The University of Queensland, which he co-headed together with Dr James Hudson from 2013-2017.
Professor Porrello is the Theme Director of Stem Cell Biology and Head of the Heart Regeneration Group at the Murdoch Children’s Research Institute. He also directs the Melbourne Node of the recently established Novo Nordisk Foundation Centre for...
Professor Porrello is the Theme Director of Stem Cell Biology and Head of the Heart Regeneration Group at the Murdoch Children’s Research Institute. He also directs the Melbourne Node of the recently established Novo Nordisk Foundation Centre for Stem Cell Medicine (reNEW) and he is the founding Co-Director of the Melbourne Centre for Cardiovascular Genomics and Regenerative Medicine (CardioRegen). Prof Porrello’s research focuses on the development of regenerative therapies for children and adults with heart failure. Over the course of his career, he has made important contributions to our understanding of mammalian heart regeneration and has pioneered the development of human organoids for drug discovery. Prof Porrello is a co-founder of Dynomics, a biotechnology company focused on the development of new heart failure treatments using organoid technologies.
After completing his PhD in Physiology at The University of Melbourne, Prof Porrello was awarded an NHMRC/NHF C.J. Martin Fellowship to undertake postdoctoral training in Prof Eric Olson's laboratory at UT Southwestern Medical Center in Dallas, USA. Upon returning to Australia in 2012, Prof Porrello established the Cardiac Regeneration Laboratory at The University of Queensland, which he co-headed together with Dr James Hudson from 2013-2017.
Top Publications
Watt, KI, Henstridge, DC, Ziemann, M, Sim, CB, Montgomery, MK, Samocha-Bonet, D, Parker, BL, Dodd, GT, Bond, ST, Salmi, TM, et al.
Yap regulates skeletal muscle fatty acid oxidation and adiposity in metabolic disease.
Nature Communications
12(1)
:
2887
2023
view publication
Phipson, B, Sim, CB, Porrello, ER, Hewitt, AW, Powell, J, Oshlack, A.
propeller: testing for differences in cell type proportions in single cell data.
2023
view publication
Mellor, KM, Varma, U, Koutsifeli, P, Curl, CL, Janssens, JV, Daniels, LJ, Bernasochi, GB, Raaijmakers, AJA, Benson, VL, Chan, EJ, et al.
Protective role of the Atg8 homologue Gabarapl1 in regulating cardiomyocyte glycophagy in diabetic heart disease.
2023
view publication
Redd, MA, Scheuer, SE, Saez, NJ, Gao, L, Hicks, M, Villanueva, JE, Reichelt, ME, Peart, JN, Hoe, LES, Chiu, HS, et al.
Acid sensing ion channel 1a is a key mediator of cardiac ischemia-reperfusion injury.
2023
view publication
Vivien, CJ, Hudson, JE, Porrello, ER.
Evolution, comparative biology and ontogeny of vertebrate heart regeneration.
npj Regenerative Medicine
1(1)
:
16012
2023
view publication